These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 8042637)

  • 21. [Somatostatin in the treatment of pancreatic diseases].
    Németh AM
    Orv Hetil; 2002 May; 143(19 Suppl):1099-108. PubMed ID: 12063869
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Management of digestive system carcinoid tumors and carcinoid syndrome].
    Mondragón Sánchez RJ; Castillero Pinilla C; Saldívar Moreno C; Oñate Ocaña LF; Ruiz Molina JM; Aiello Crocifoglio V
    Rev Gastroenterol Mex; 1998; 63(4):204-10. PubMed ID: 10319670
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Efficacy of the somatostatin analog octreotide in the treatment of two patients with refractory diabetic diarrhea.
    Walker JJ; Kaplan DS
    Am J Gastroenterol; 1993 May; 88(5):765-7. PubMed ID: 8480746
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Clinical application of somatostatin-analogue].
    Tanaka K; Itoh S; Shimizu N
    Nihon Rinsho; 1990 May; 48(5):1084-8. PubMed ID: 2165538
    [No Abstract]   [Full Text] [Related]  

  • 25. Try this drug when AIDS-related diarrhea won't quit.
    RN; 1994 Dec; 57(12):71. PubMed ID: 7817143
    [No Abstract]   [Full Text] [Related]  

  • 26. Potential indications for octreotide in endocrinology.
    von Werder K; Faglia G
    Metabolism; 1992 Sep; 41(9 Suppl 2):91-8. PubMed ID: 1518441
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Marked improvement of diabetic diarrhea with the somatostatin analogue octreotide.
    Nakabayashi H; Fujii S; Miwa U; Seta T; Takeda R
    Arch Intern Med; 1994 Aug; 154(16):1863-7. PubMed ID: 8053756
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Experience in treating acromegalic patients with long-acting octreotide].
    Szücs N; Mészáros J; Czirják S; Mondok A; Varga I; Gláz E
    Orv Hetil; 2002 May; 143(19 Suppl):1066-70. PubMed ID: 12063862
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Carcinoid tumor--diagnostic and therapeutic problems].
    Batowski S; Bielewicz A
    Pol Tyg Lek; 1994 Jun 6-13; 49(23-24):536-7. PubMed ID: 7675710
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Therapeutic applications of somatostatin and its analog, octreotide].
    Harris AG; Kokoris SP
    Presse Med; 1993 Apr; 22(15):724-33. PubMed ID: 8099737
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Efficacy of octreotide in the management of chronic diarrhoea in AIDS.
    Colebunders R; Sow S; Coulibaly M; Blot K
    AIDS; 1992 May; 6(5):512. PubMed ID: 1616659
    [No Abstract]   [Full Text] [Related]  

  • 32. Regarding: Rosenthal DI, Glatstein E. "We've Got a Treatment, but What's the Disease?" The Oncologist 1996;1.
    Lunsford LD; Flickinger JC; Larson D
    Oncologist; 1997; 2(1):59-61. PubMed ID: 10388030
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Octreotide in the management of active acromegaly due to inoperable growth hormone-secreting adenoma.
    Candrina R
    Recenti Prog Med; 1994 Jan; 85(1):13-9. PubMed ID: 8184174
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Pre-clinical and clinical experiences with novel somatostatin ligands: advantages, disadvantages and new prospects.
    Hofland LJ; van der Hoek J; Feelders R; van der Lely AJ; de Herder W; Lamberts SW
    J Endocrinol Invest; 2005; 28(11 Suppl International):36-42. PubMed ID: 16625843
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Clinical efficacy and safety of octreotide (SMS201-995) in terminally ill Japanese cancer patients with malignant bowel obstruction.
    Shima Y; Ohtsu A; Shirao K; Sasaki Y
    Jpn J Clin Oncol; 2008 May; 38(5):354-9. PubMed ID: 18490369
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Consensus statement: octreotide dose titration in secretory diarrhea. Diarrhea Management Consensus Development Panel.
    Harris AG; O'Dorisio TM; Woltering EA; Anthony LB; Burton FR; Geller RB; Grendell JH; Levin B; Redfern JS
    Dig Dis Sci; 1995 Jul; 40(7):1464-73. PubMed ID: 7628270
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Medical management of acromegaly--what and when?
    Melmed S
    Acta Endocrinol (Copenh); 1993 Jul; 129 Suppl 1():13-7. PubMed ID: 8372605
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Octreotide use in AIDS.
    Pon D; Dong BJ
    DICP; 1990 Oct; 24(10):951-2. PubMed ID: 2244409
    [No Abstract]   [Full Text] [Related]  

  • 39. Primary octreotide LAR therapy in GH-secreting pituitary adenoma.
    Harinarayan CV
    J Indian Med Assoc; 2004 May; 102(5):258, 260-1. PubMed ID: 15636029
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A multicenter, randomized trial of long-acting octreotide for the optimum prevention of chemotherapy-induced diarrhea: results of the STOP trial.
    Rosenoff SH; Gabrail NY; Conklin R; Hohneker JA; Berg WJ; Warsi G; Maloney J; Benedetto JJ; Miles EA; Zhu W; Anthony L
    J Support Oncol; 2006 Jun; 4(6):289-94. PubMed ID: 16805331
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.